These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 93828)

  • 1. Recent advances in applied malaria immunology.
    Speer CA; Silverman PH
    Z Parasitenkd; 1979 Nov; 60(1):3-17. PubMed ID: 93828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain-transcending neutralization of malaria parasite by antibodies against Plasmodium falciparum enolase.
    Dutta S; Tewari A; Balaji C; Verma R; Moitra A; Yadav M; Agrawal P; Sahal D; Jarori GK
    Malar J; 2018 Aug; 17(1):304. PubMed ID: 30126436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of resistance in mice to sporozoite-induced Plasmodium berghei malaria by injections of avian exoerythrocytic forms.
    Holbrook TW; Spitalny GL; Palczuk NC
    J Parasitol; 1976 Oct; 62(5):670-5. PubMed ID: 789848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite.
    Friesen J; Matuschewski K
    Vaccine; 2011 Sep; 29(40):7002-8. PubMed ID: 21787828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.
    Sina BJ; do Rosario VE; Woollett G; Sakhuja K; Hollingdale MR
    Exp Parasitol; 1993 Sep; 77(2):129-35. PubMed ID: 8375482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites.
    Schofield L; Villaquiran J; Ferreira A; Schellekens H; Nussenzweig R; Nussenzweig V
    Nature; 1987 Dec 17-23; 330(6149):664-6. PubMed ID: 3120015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria vaccine.
    Khurana SK; Talib VH
    Indian J Pathol Microbiol; 1996 Dec; 39(5):433-41. PubMed ID: 9002371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole parasite vaccination approaches for prevention of malaria infection.
    Butler NS; Vaughan AM; Harty JT; Kappe SH
    Trends Immunol; 2012 May; 33(5):247-54. PubMed ID: 22405559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a sporozoite antigen common to Plasmodium falciparum and Plasmodium berghei.
    Sina BJ; Wright C; Atkinson CT; Ballou R; Aikawa M; Hollingdale M
    Mol Biochem Parasitol; 1995 Feb; 69(2):239-46. PubMed ID: 7770087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium berghei circumsporozoite protein encapsulated in oligomannose-coated liposomes confers protection against sporozoite infection in mice.
    Terkawi MA; Kuroda Y; Fukumoto S; Tanaka S; Kojima N; Nishikawa Y
    Malar J; 2014 Nov; 13():426. PubMed ID: 25373617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites.
    Tsuji M; Mattei D; Nussenzweig RS; Eichinger D; Zavala F
    Parasitol Res; 1994; 80(1):16-21. PubMed ID: 8153120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoprotection in mice susceptible to waning memory against the pre-erythrocytic stages of malaria after validated immunisation with irradiated sporozoites of Plasmodium berghei.
    Winger LA; Sinden RE
    Parasitol Res; 1992; 78(5):427-32. PubMed ID: 1495922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of murine malaria sporozoite vaccines: implications for human vaccine development.
    Egan JE; Weber JL; Ballou WR; Hollingdale MR; Majarian WR; Gordon DM; Maloy WL; Hoffman SL; Wirtz RA; Schneider I
    Science; 1987 Apr; 236(4800):453-6. PubMed ID: 3551073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages.
    Nardin EH; Nussenzweig RS
    Annu Rev Immunol; 1993; 11():687-727. PubMed ID: 8476576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signatures of malaria vaccine efficacy in ageing murine immune memory.
    Haussig JM; Burgold J; Hafalla JC; Matuschewski K; Kooij TW
    Parasite Immunol; 2014 May; 36(5):199-206. PubMed ID: 24495208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.
    Billman ZP; Kas A; Stone BC; Murphy SC
    Malar J; 2016 Apr; 15():238. PubMed ID: 27113469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
    Nardin E; Zavala F; Nussenzweig V; Nussenzweig RS
    Parassitologia; 1999 Sep; 41(1-3):397-402. PubMed ID: 10697892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live attenuated pre-erythrocytic malaria vaccines.
    Keitany GJ; Vignali M; Wang R
    Hum Vaccin Immunother; 2014; 10(10):2903-9. PubMed ID: 25483648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.